Gapping up In reaction to strong earnings/guidance: PWE +8.1%, ROSG +5.4%, STLD +4.6%, MLHR +3.4%, CAG +2.8%, UNFI +2%, CLC +1.6%
M&A news: SODA +3.1% (story making the rounds suggesting M&A from DEO, KKR or SBMRY), SNN +1.9% (renewed M&A spec post Stryker (SYK) analyst meeting), WWAV +1.8% (acquires So Delicious Dairy Free for ~$195 mln in cash)
Other news: EMKR +45.7% (announces the sale of its Space Photovoltaics Business to Veritas Capital, announces CEO transition plan), BAXS +20% (to explore strategic alternatives for its MIS Spine Business), XXII +18.7% (enters cannabis space; acquires exclusive U.S. license to Cannabinoid Biosynthesis Genes and takes 25% stake in biotechnology company), VVUS +17.8% (Vivus and Auxilium (AUXL) announce FDA approval of STENDRA sNDA), WYY +8.4% (subsidiary iSYS receives task order from U.S. Citizenship and Immigration Services), RSH +8.2% (cont pre-mkt vol), CGEN +4.2% (still checking), GILT +3.3% (still checking), SONS +3.3% (board of directors voted to terminate the co's shareholder rights plan effective Sep 17, 2014), MOBI +3.2% (announces strategic partnership with China Telecom (CHA)), ERIC +3.2% (announced it will discontinue future development of modems and shift parts of resources in modems to radio network R&D ), NETE +3% (CEO Oleg Firer discloses 6.5% stake), STM +1.9% (may be moving with ERIC), A +1.8% (transition of CEO: Mike McMullen to succeed Bill Sullivan in March 2015; creates new group for services and consumables), CY +1.7% (favorable commentary on Wednesday's Mad Money), ISIS +1.7% (favorable commentary on Wednesday's Mad Money), YHOO +1.2% (cont momentum ahead of BABA IPO), X +0.9% (in sympathy with STLD), OVTI +0.8% (Hua Capital Management hired bankers to fund possible OVTI bid, according to reports), INFY +0.6% (announced a global partnerships with Huawei, MSFT, and Hitachi for various products/svcs), AAPL +0.6% (iPhone 6 has received 1 China license, according to reports)
Analyst comments: IOC +4.1% (initiated with a Outperform at Credit Suisse), TKMR +2.4% (positive commentary at Maxim), VNCE +1.6% (initiated with a Buy at B. Riley & Co), KSS +1.3% (upgraded to Buy from Neutral at Citigroup), RYI +1.1% (initiated with a Buy at KeyBanc Capital Mkts), MON +1% (upgraded to Buy at Stifel), MT +0.8% (upgraded to Buy from Neutral at BofA/Merrill), DD +0.7% (upgraded to Overweight from Neutral at JP Morgan), BXP +0.6% (upgraded to Buy at Stifel), BA +0.5% (added to Franchise Pick list at Jefferies)